New drug combo tested for Tough-to-Treat gynecologic cancers
NCT ID NCT05990803
Summary
This study is testing two experimental drugs, BL-B01D1 and SI-B003, to see if they can help control advanced cervical and other gynecological cancers that have returned or spread. Researchers will give the drugs separately and together to about 130 patients to find the most effective and safest approach. The main goals are to see if tumors shrink and to determine the best dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.